Canopy Growth Corporation (CGC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this company have returned +40.5% over the past month versus the Zacks S&P 500 composite's +5% change. The Zacks Medical - Products industry, to which Canopy Growth belongs, has gained 3.5% over this period. Now the key question is: Where could the stock be headed in the near term? While m ...

Canopy Growth is part of the Zacks Medical - Products industry. Aurora Cannabis Inc. (ACB) , another stock in the same industry, closed the last trading session 6.9% higher at $7.61. ACB has returned 23% in the past month. Canopy Growth Corporation (CGC) shares ended the last trading session 11% higher at $11. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 52.7% gain over the past four weeks. The surge in Canopy G ...

Following the release of its fourth quarter and fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on May 30, at 10 AM Eastern Time. Webcast Information SMITHS FALLS, ON, May 16, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis, will release its financial results for the fourth quarter and fiscal year 2024 ...

Key Canadian Cannabis Stocks to Watch in Mid-May 2024 As we explore the bustling Canadian cannabis market, several marijuana stocks stand out this week, warranting a closer look. These companies, thriving amid a globally expanding industry, have shown resilience and innovation. Recent statistics reveal the global cannabis market could reach USD 197.74 billion by 2028, according to Grand View Research. This forecast underscores significant growth potential, driven by increasing legalization and medical usage ...

Pot stocks can sometimes trade like meme stocks, and investors need to be careful, or they may incur significant losses.Cannabis stocks were surging last week on the news that the Drug Enforcement Administration (DEA) is going to reclassify marijuana. It will no longer be a Schedule I drug alongside heroin and LSD. Instead, it will be moved to Schedule III, where ketamine and certain anabolic steroids are grouped.Usually, when there's some positive news around marijuana reform, shares of Tilray Brands (TLRY ...

The Best 3 Marijuana Stocks For Your 2024 WatchlistWhat will happen to marijuana stocks if cannabis does not get rescheduled? Some see this as a possibility and investors want to be prepared. With all the recent talks of cannabis being dropped from a scheduled 1 to a class 3 substance it has led to a rise in trading. The speculation of what’s next to come is also feeding into momentum pouring into the sector.The goal should be the reclassification of cannabis and putting it into the same place as alcohol an ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

SMITHS FALLS, ON, May 7, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today confirmed that Canopy USA, LLC ("Canopy USA") has exercised the options to acquire Wana and Jetty (each as defined below). The exercise of these options is a critical next step to enable Canopy USA to fulfill its intent to establish a leading, brand-focused powerhouse. It is also expected that once completed, these acquisitions will enable Canopy USA to realize compelling ...

C$27.5 Millon of Debt Extended from 2025 to 2029 Providing Additional Balance Sheet Flexibility SMITHS FALLS, ON, May 3, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that on May 2, 2024, it entered into an exchange and subscription agreement (the "Agreement") with a single institutional investor (the "Investor") pursuant to which Canopy Growth is expected to receive gross proceeds of approximately US$50 million and exchange appro ...

Investors are taking profits on marijuana stocks today, but the long-term trend still looks up.Easy come, easy go. Yesterday, shares of cannabis companies like Canopy Growth (CGC -25.96%), Tilray Brands (TLRY -17.01%), and Cronos Group (CRON -7.14%) all soared on news that the U.S. Drug Enforcement Administration (DEA) has agreed to recommend downgrading marijuana from a Schedule I drug to a Schedule III drug. Already today, the high is starting to wear off.As of 11:15 a.m. ET Wednesday, Canopy Growth stock ...